Type 2 diabetes trials in China

In China 189 Also abroad 1200

189 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes
Where
Beihai, Guilin, Nanning, Qingdao
Age
18 years to 80 years
People
10,000
Run by
Second Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT06959030
No phaseTaking people
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
Where
Beijing
Age
40 years to 80 years
People
68
Run by
Xuxiang Zhang, MD
See details and how to joinNCT06713720
Phase 4Taking people
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
Where
Wuhan
Age
18 years and over
People
170
Run by
Huazhong University of Science and Technology
See details and how to joinNCT07019012
No phaseNot yet taking people in China
DCB for CAD With Type 2 Diabetes
Where
Kaifeng, Luoyang, Ningbo, Shanghai, Yibin, Zhengzhou
Age
18 years and over
People
1,000
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT07009938
No phaseTaking people
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
Where
Ningbo
Age
20 years to 90 years
People
2,720
Run by
Ningbo No. 1 Hospital
See details and how to joinNCT06984510
No phaseEnrolling by invitation
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
Where
Shanghai
Age
18 years to 75 years
People
46
Run by
Shanghai East Hospital
See details and how to joinNCT06924697
No phaseTaking people
Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression
Where
Nantong
Age
18 years to 65 years
People
40
Run by
Affiliated Hospital of Nantong University
See details and how to joinNCT06979440
Phase 1Not yet taking people in China
A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
Where
Beijing
Age
18 years to 60 years
People
30
Run by
Gan & Lee Pharmaceuticals.
See details and how to joinNCT06974487
No phaseTaking people
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
Where
Suzhou
Age
65 years and over
People
5,600
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT05349955
No phaseTaking people
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
Where
Beijing, Changchun, Guangzhou, Harbin, Luzhou, Nanjing, Tianjin, Xi'an, Xuzhou, Zhengzhou
Age
18 years to 70 years
People
115
Run by
Beijing Hospital
See details and how to joinNCT03987308
Phase 4Taking people
Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
Where
Beijing
Age
30 years to 75 years
People
356
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT06932874
Phase 3Not yet taking people in China
New Triple Therapy in Newly Diagnosed Type 2 Diabetes
Where
Guangzhou
Age
18 years to 75 years
People
296
Run by
Sun Yat-sen University
See details and how to joinNCT06946628
Phase 4Enrolling by invitation
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
Where
Beijing
Age
18 years to 75 years
People
170
Run by
Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT06925334
No phaseTaking people
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Where
Suzhou
Age
18 years and over
People
300
Run by
Second Affiliated Hospital of Soochow University
See details and how to joinNCT06838416
No phaseTaking people
Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）
Where
Nanjing
Age
45 years to 70 years
People
400
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06912321
No phaseTaking people
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
Where
Hangzhou
Age
18 years to 74 years
People
80
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06863532
Phase 2/3Not yet taking people in China
Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes
Where
Shanghai
Age
18 years and over
People
60
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT06847178
Phase 3Taking people
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
Where
Nanjing
Age
18 years and over
People
1,000
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06825182
Phase 4Taking people
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Where
Xiamen
Age
18 years to 75 years
People
164
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT03087032
Phase 4Not yet taking people in China
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
Where
Nanjing
Age
18 years to 75 years
People
190
Run by
Xiqiao Zhou
See details and how to joinNCT06762223
Phase 3Taking people
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Where
Nanjing
Age
60 years and over
People
260
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06361238
Phase 2Taking people
Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus
Where
Shanghai
Age
18 years to 70 years
People
10
Run by
Lu jin ，MD
See details and how to joinNCT06727721
No phaseTaking people
China Diabetes Registry by Metabolic Management Center
Where
Multiple Locations
Age
18 years and over
People
1,000,000
Run by
Guang Ning
See details and how to joinNCT03811470
No phaseTaking people
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control
Where
Shanghai
Age
18 years to 80 years
People
150
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT06591286
No phaseTaking people
China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)
Where
Nanjing
Age
45 years and over
People
10,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06650969